BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23801675)

  • 1. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.
    Zukotynski KA; Fahey FH; Vajapeyam S; Ng SS; Kocak M; Gururangan S; Kun LE; Poussaint TY
    J Nucl Med; 2013 Aug; 54(8):1237-43. PubMed ID: 23801675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium.
    Zukotynski K; Fahey F; Kocak M; Kun L; Boyett J; Fouladi M; Vajapeyam S; Treves T; Poussaint TY
    J Nucl Med; 2014 Sep; 55(9):1473-80. PubMed ID: 25071098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of
    Zukotynski KA; Vajapeyam S; Fahey FH; Kocak M; Brown D; Ricci KI; Onar-Thomas A; Fouladi M; Poussaint TY
    J Nucl Med; 2017 Aug; 58(8):1264-1269. PubMed ID: 28360212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
    Zukotynski KA; Fahey FH; Kocak M; Alavi A; Wong TZ; Treves ST; Shulkin BL; Haas-Kogan DA; Geyer JR; Vajapeyam S; Boyett JM; Kun LE; Poussaint TY
    J Nucl Med; 2011 Feb; 52(2):188-95. PubMed ID: 21233173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC).
    Williams G; Fahey FH; Treves ST; Kocak M; Pollack IF; Boyett JM; Kun LE; Poussaint TY
    Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1651-8. PubMed ID: 18425516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
    Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
    Prieto E; Martí-Climent JM; Domínguez-Prado I; Garrastachu P; Díez-Valle R; Tejada S; Aristu JJ; Peñuelas I; Arbizu J
    J Nucl Med; 2011 Jun; 52(6):865-72. PubMed ID: 21571807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
    Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
    J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
    Seligman L; Kovanlikaya I; Pisapia DJ; Naeger DM; Magge R; Fine HA; Chiang GC
    AJR Am J Roentgenol; 2019 Apr; 212(4):883-891. PubMed ID: 30779663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
    Holodny AI; Makeyev S; Beattie BJ; Riad S; Blasberg RG
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1042-8. PubMed ID: 20150307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
    Sacconi B; Raad RA; Lee J; Fine H; Kondziolka D; Golfinos JG; Babb JS; Jain R
    J Neurooncol; 2016 Apr; 127(2):287-93. PubMed ID: 26729270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
    Tripathi M; Sharma R; Varshney R; Jaimini A; Jain J; Souza MM; Bal J; Pandey S; Kumar N; Mishra AK; Mondal A
    Clin Nucl Med; 2012 Feb; 37(2):158-63. PubMed ID: 22228339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment
    Gong C; Ma G; Hu X; Zhang Y; Wang Z; Zhang J; Zhao Y; Li Y; Xie Y; Yang Z; Wang B
    Oncologist; 2018 Oct; 23(10):1144-1152. PubMed ID: 30082489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma.
    Gururangan S; Hwang E; Herndon JE; Fuchs H; George T; Coleman RE
    Neurosurgery; 2004 Dec; 55(6):1280-8; discussion 1288-9. PubMed ID: 15574210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of
    He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
    BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.